Nucleos(t)ide withdrawal versus nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B trial)

Mark Thursz, Maud Lemoine, Ashley Brown, Ivana Carey, Jack Message, Patrick Kennedy, Daniel Forton, Martin Wiselka, Mark Aldersley, Martin Prince, Stuart McPherson, Sandra Phillips, Shilpa Chokshi, Alice Burton, Mala Maini, Johannes Christiaan Botha, Eleni Nastouli, Samantha Tsao, Emanuela Falaschetti, Hanna Box, Mariam Habib, Kaushik Agarwal, Unknown

Open source

DOI
10.1097/hep.0000000000001821
Published
2026-08-04
Container
Hepatology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/hep.0000000000001821,
  title = {Nucleos(t)ide withdrawal versus nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B trial)},
  author = {Mark Thursz and Maud Lemoine and Ashley Brown and Ivana Carey and Jack Message and Patrick Kennedy and Daniel Forton and Martin Wiselka and Mark Aldersley and Martin Prince and Stuart McPherson and Sandra Phillips and Shilpa Chokshi and Alice Burton and Mala Maini and Johannes Christiaan Botha and Eleni Nastouli and Samantha Tsao and Emanuela Falaschetti and Hanna Box and Mariam Habib and Kaushik Agarwal and Unknown},
  year = {2026},
  journal = {Hepatology},
  doi = {10.1097/hep.0000000000001821},
  url = {https://doi.org/10.1097/hep.0000000000001821}
}

RIS

TY  - JOUR
TI  - Nucleos(t)ide withdrawal versus nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B trial)
AU  - Mark Thursz
AU  - Maud Lemoine
AU  - Ashley Brown
AU  - Ivana Carey
AU  - Jack Message
AU  - Patrick Kennedy
AU  - Daniel Forton
AU  - Martin Wiselka
AU  - Mark Aldersley
AU  - Martin Prince
AU  - Stuart McPherson
AU  - Sandra Phillips
AU  - Shilpa Chokshi
AU  - Alice Burton
AU  - Mala Maini
AU  - Johannes Christiaan Botha
AU  - Eleni Nastouli
AU  - Samantha Tsao
AU  - Emanuela Falaschetti
AU  - Hanna Box
AU  - Mariam Habib
AU  - Kaushik Agarwal
AU  - Unknown
PY  - 2026
JO  - Hepatology
DO  - 10.1097/hep.0000000000001821
UR  - https://doi.org/10.1097/hep.0000000000001821
ER  - 

APA

Thursz, M., Lemoine, M., Brown, A., Carey, I., Message, J., Kennedy, P., Forton, D., Wiselka, M., Aldersley, M., Prince, M., McPherson, S., Phillips, S., Chokshi, S., Burton, A., Maini, M., Botha, J. C., Nastouli, E., Tsao, S., Falaschetti, E., Box, H., Habib, M., Agarwal, K., & Unknown (2026). Nucleos(t)ide withdrawal versus nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B trial). Hepatology. https://doi.org/10.1097/hep.0000000000001821

Source records